查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1542535

全球間質幹細胞市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測

Global Mesenchymal Stem Cells Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 234 Pages | 商品交期: 最快1-2個工作天內

價格

全球間質幹細胞市場需求預計將從 2023 年的 31.8 億美元達到 2032 年近 99.3 億美元的市場規模，2024-2032 年研究期間複合年成長率為 13.5%。

間質幹細胞（MSC）是一種多功能成體幹細胞，存在於骨髓、脂肪組織和臍帶血等多種身體組織中。間質幹細胞具有轉化為骨骼、軟骨、脂肪和肌肉細胞等不同細胞類型的卓越能力，在再生醫學和組織工程領域具有巨大的潛力。除了分化能力之外，間質幹細胞還表現出免疫調節特性，在調節免疫反應和促進組織修復和再生過程中發揮關鍵作用。這種獨特的特徵組合使它們成為治療骨科損傷、心血管疾病或自體免疫疾病等多種疾病的有希望的候選藥物。

市場動態

間質幹細胞（MSC）市場受到塑造再生醫學和細胞治療格局的多種因素的推動。首先，人們對間質幹細胞在組織修復、免疫調節和再生醫學方面的治療潛力的日益了解，推動了對基於間質幹細胞的治療各種疾病的需求，包括骨科疾病、自體免疫疾病和神經系統疾病。此外，慢性病、人口老化和生活方式相關疾病的盛行率不斷上升，推動了對創新治療方式的需求，這些方式有可能解決未滿足的醫療需求並改善患者的治療結果。此外，細胞培養技術、細胞分離方法和冷凍保存技術的進步使得基於間質幹細胞的療法的可擴展生產和臨床轉化成為可能，從而推動市場擴張和可及性。

此外，基於 MSC 的產品和療法的監管批准和臨床驗證支持市場成長以及醫療保健提供者和患者的採用。此外，生物技術公司、學術研究機構和製藥公司之間的策略合作、夥伴關係和投資推動了基於 MSC 的療法的創新、產品開發和商業化，促進市場成長和競爭力。此外，增加對臨床研究、臨床前研究和轉化醫學計劃的投資有助於間質幹細胞市場的擴大和新型治療應用的開發。然而，製造可擴展性、產品品質標準化和監管合規性等挑戰可能會阻礙未來幾年間充質幹細胞市場的成長，因此需要繼續努力解決這些障礙並釋放基於間質幹細胞的療法在再生醫學中的全部潛力和細胞療法。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球間質幹細胞市場的各個細分市場進行了包容性評估。間質幹細胞產業的成長和趨勢為這項研究提供了整體方法。

市場區隔

間質幹細胞市場報告的這一部分提供了國家和區域層面細分市場的詳細資料，從而幫助策略家確定相應產品或服務的目標人群以及即將到來的機會。

按產品和服務

  • 產品（細胞和細胞系、試劑盒、培養基和試劑、其他）
  • 服務

按工作流程

  • 細胞採購與分離
  • 培養與冷凍保存
  • 差異化
  • 表徵

按類型

  • 自體
  • 同種異體

按隔離來源分類

  • 骨髓
  • 臍帶血
  • 周邊血
  • 輸卵管
  • 胎兒肝臟
  • 肺
  • 脂肪組織

按指示

  • 骨骼和軟骨修復
  • 心血管疾病
  • 發炎和免疫性疾病
  • 肝臟疾病
  • 癌症
  • 移植物抗宿主疾病
  • 其他

按申請

  • 疾病建模
  • 藥物開發與發現
  • 幹細胞銀行
  • 組織工程
  • 毒理學研究
  • 其他

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲間質幹細胞市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。間質幹細胞市場的主要參與者包括Thermo Fisher Scientific Inc.、Cell Applications Inc.、Axol Biosciences Ltd.、Cytori Therapeutics Inc.、STEMCELL Technologies、Cyagen Biosciences.、Celprogen Inc.、BrainStorm Cell Limited.、Stemedica Cell Technologies Technologies Technologies Technologies Technologies Technologies Technologies Inc.、 Merck KGaA (MilliporeSigma)、Lonza、PromoCell GmbH。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第1章：前言

  • 報告說明
    • 客觀的
    • 目標受眾
    • 獨特的銷售主張 (USP) 和產品
  • 研究範圍
  • 研究方法
    • 市場研究過程
    • 市場研究方法論

第 2 章：執行摘要

  • 市場亮點
  • 全球市場概況

第 3 章：間質幹細胞 - 產業分析

  • 簡介 - 市場動態
  • 市場促進因素
  • 市場限制
  • 機會
  • 產業動態
  • 波特五力分析
  • 市場吸引力分析
    • 按產品和服務分類的市場吸引力分析
    • 依工作流程進行市場吸引力分析
    • 按類型分類的市場吸引力分析
    • 按隔離來源進行的市場吸引力分析
    • 按指標進行的市場吸引力分析
    • 市場吸引力分析：依應用分類
    • 市場吸引力分析：按地區

第 4 章：價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料廠商清單
    • 主要原物料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直效行銷
    • 間接行銷
    • 行銷通路發展趨勢

第 5 章：全球間質幹細胞市場分析：依產品與服務分類

  • 按產品和服務分類的概述
  • 歷史和預測數據
  • 按產品和服務分析
  • 產品（細胞和細胞系、試劑盒、培養基和試劑、其他）
  • 服務

第 6 章：全球間質幹細胞市場分析：依工作流程

  • 按工作流程概述
  • 歷史和預測數據
  • 按工作流程分析
  • 細胞採購與分離
  • 培養與冷凍保存
  • 差異化
  • 表徵

第 7 章：全球間質幹細胞市場分析：依類型

  • 按類型概述
  • 歷史和預測數據
  • 按類型分析
  • 自體
  • 同種異體

第 8 章：全球間質幹細胞市場分析：依隔離來源分類

  • 按隔離源分類的概述
  • 歷史和預測數據
  • 按隔離源分析
  • 骨髓
  • 臍帶血
  • 周邊血
  • 輸卵管
  • 胎兒肝臟
  • 肺
  • 脂肪組織

第 9 章：全球間質幹細胞市場分析：依適應症分類

  • 按適應症概述
  • 歷史和預測數據
  • 按指標分析
  • 骨骼和軟骨修復
  • 心血管疾病
  • 發炎和免疫性疾病
  • 肝臟疾病
  • 癌症
  • 移植物抗宿主疾病
  • 其他

第 10 章：全球間質幹細胞市場分析：依應用分類

  • 概述：按應用
  • 歷史和預測數據
  • 分析：按應用
  • 疾病建模
  • 藥物開發與發現
  • 幹細胞銀行
  • 組織工程
  • 毒理學研究
  • 其他

第 11 章：全球間質幹細胞市場分析：依地理位置

  • 區域展望
  • 介紹
  • 北美銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 北美按細分市場銷售分析
    • 北美按國家銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 歐洲按細分市場銷售分析
    • 歐洲按國家銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 亞太地區按細分市場銷售分析
    • 亞太地區國家/地區銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳洲銷售分析
    • 亞太地區其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 拉丁美洲按細分市場銷售分析
    • 拉丁美洲按國家銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 中東和非洲按細分市場銷售分析
    • 中東和非洲國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東其他地區和非洲銷售分析

第 12 章：間質幹細胞公司的競爭格局

  • 間質幹細胞市場競爭
  • 夥伴關係/協作/協議
  • 併購
  • 新產品發布
  • 其他發展

第 13 章：公司簡介

  • 公司股份分析
  • 市場集中度
  • Thermo Fisher Scientific Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Cell Applications Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Axol Biosciences Ltd.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Cytori Therapeutics Inc
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • STEMCELL Technologies
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Cyagen Biosciences.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Celprogen Inc
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • BrainStorm Cell Limited.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Stemedica Cell Technologies Inc
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Merck KGaA (MilliporeSigma)
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Lonza
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • PromoCell GmbH
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態

注意 - 在公司概況中，財務詳細資訊和近期發展視情況而定，或者如果是私人公司，則可能不包括在內

Product Code: VMR11219961

The global demand for Mesenchymal Stem Cells Market is presumed to reach the market size of nearly USD 9.93 Billion by 2032 from USD 3.18 Billion in 2023 with a CAGR of 13.5% under the study period 2024 - 2032.

Mesenchymal stem cells, or in short MSCs are a type of versatile adult stem cell present in various bodily tissues such as bone marrow, adipose tissue, and umbilical cord blood. With their remarkable ability to transform into different cell types like bone, cartilage, fat, and muscle cells, MSCs hold immense potential in the fields of regenerative medicine and tissue engineering. Beyond their differentiation capabilities, MSCs also exhibit immunomodulatory characteristics, playing a pivotal role in regulating immune responses and facilitating tissue repair and regeneration processes. This unique combination of traits has positioned them as promising candidates for treating a wide array of medical conditions, such as orthopedic injuries, cardiovascular diseases or autoimmune disorders.

MARKET DYNAMICS

The Mesenchymal Stem Cells (MSCs) market is propelled by several factors shaping the landscape of regenerative medicine and cell therapy. Firstly, the increasing understanding of MSCs' therapeutic potential in tissue repair, immunomodulation, and regenerative medicine drives the demand for MSC-based therapies for various medical conditions, including orthopedic disorders, autoimmune diseases, and neurological disorders. Additionally, the rising prevalence of chronic diseases, aging population, and lifestyle-related ailments fuel the need for innovative treatment modalities with the potential to address unmet medical needs and improve patient outcomes. Moreover, advancements in cell culture techniques, cell isolation methods, and cryopreservation technologies enable the scalable production and clinical translation of MSC-based therapies, driving market expansion and accessibility.

Furthermore, the regulatory approvals and clinical validation of MSC-based products and therapies support market growth and adoption by healthcare providers and patients. Additionally, strategic collaborations, partnerships, and investments among biotechnology companies, academic research institutions, and pharmaceutical companies drive innovation, product development, and commercialization of MSC-based therapies, fostering market growth and competitiveness. Furthermore, increasing investments in clinical research, preclinical studies, and translational medicine initiatives contribute to the expansion of the MSCs market and the development of novel therapeutic applications. However, challenges such as manufacturing scalability, standardization of product quality, and regulatory compliance may hinder the growth of the MSCs market in the next few years, necessitating continued efforts to address these hurdles and unlock the full potential of MSC-based therapies in regenerative medicine and cell therapy.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain Analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of mesenchymal stem cells. The growth and trends of the mesenchymal stem cells industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the mesenchymal stem cells market report provides detailed data on the segments at the country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product & Services

  • Products (Cells & Cell Lines, Kits, Media, & Reagents, Others)
  • Services

By Workflow

  • Cell Sourcing & Isolation
  • Culture & Cryopreservation
  • Differentiation
  • Characterization

By Type

  • Autologous
  • Allogeneic

By Source Of Isolation

  • Bone Marrow
  • Cord Blood
  • Peripheral Blood
  • Fallopian Tube
  • Fetal Liver
  • Lung
  • Adipose Tissues

By Indication

  • Bone And Cartilage Repair
  • Cardiovascular Disease
  • Inflammatory And Immunological Diseases
  • Liver Diseases
  • Cancer
  • GvHD
  • Others

By Application

  • Disease Modelling
  • Drug Development & Discovery
  • Stem Cell Banking
  • Tissue Engineering
  • Toxicology Studies
  • Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Mesenchymal Stem Cells market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Mesenchymal Stem Cells market include Thermo Fisher Scientific Inc., Cell Applications Inc., Axol Biosciences Ltd., Cytori Therapeutics Inc, STEMCELL Technologies, Cyagen Biosciences., Celprogen Inc, BrainStorm Cell Limited., Stemedica Cell Technologies Inc, Merck KGaA (MilliporeSigma), Lonza, PromoCell GmbH. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . MESENCHYMAL STEM CELLS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product & Services
    • 3.7.2 Market Attractiveness Analysis By Workflow
    • 3.7.3 Market Attractiveness Analysis By Type
    • 3.7.4 Market Attractiveness Analysis By Source Of Isolation
    • 3.7.5 Market Attractiveness Analysis By Indication
    • 3.7.6 Market Attractiveness Analysis By Application
    • 3.7.7 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL MESENCHYMAL STEM CELLS MARKET ANALYSIS BY PRODUCT & SERVICES

  • 5.1 Overview by Product & Services
  • 5.2 Historical and Forecast Data
  • 5.3 Analysis by Product & Services
  • 5.4 Products (Cells & Cell Lines, Kits, Media, & Reagents, Others) Historic and Forecast Sales by Regions
  • 5.5 Services Historic and Forecast Sales by Regions

6 . GLOBAL MESENCHYMAL STEM CELLS MARKET ANALYSIS BY WORKFLOW

  • 6.1 Overview by Workflow
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Workflow
  • 6.4 Cell Sourcing & Isolation Historic and Forecast Sales by Regions
  • 6.5 Culture & Cryopreservation Historic and Forecast Sales by Regions
  • 6.6 Differentiation Historic and Forecast Sales by Regions
  • 6.7 Characterization Historic and Forecast Sales by Regions

7 . GLOBAL MESENCHYMAL STEM CELLS MARKET ANALYSIS BY TYPE

  • 7.1 Overview by Type
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Type
  • 7.4 Autologous Historic and Forecast Sales by Regions
  • 7.5 Allogeneic Historic and Forecast Sales by Regions

8 . GLOBAL MESENCHYMAL STEM CELLS MARKET ANALYSIS BY SOURCE OF ISOLATION

  • 8.1 Overview by Source Of Isolation
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by Source Of Isolation
  • 8.4 Bone Marrow Historic and Forecast Sales by Regions
  • 8.5 Cord Blood Historic and Forecast Sales by Regions
  • 8.6 Peripheral Blood Historic and Forecast Sales by Regions
  • 8.7 Fallopian Tube Historic and Forecast Sales by Regions
  • 8.8 Fetal Liver Historic and Forecast Sales by Regions
  • 8.9 Lung Historic and Forecast Sales by Regions
  • 8.10. Adipose Tissues Historic and Forecast Sales by Regions

9 . GLOBAL MESENCHYMAL STEM CELLS MARKET ANALYSIS BY INDICATION

  • 9.1 Overview by Indication
  • 9.2 Historical and Forecast Data
  • 9.3 Analysis by Indication
  • 9.4 Bone And Cartilage Repair Historic and Forecast Sales by Regions
  • 9.5 Cardiovascular Disease Historic and Forecast Sales by Regions
  • 9.6 Inflammatory And Immunological Diseases Historic and Forecast Sales by Regions
  • 9.7 Liver Diseases Historic and Forecast Sales by Regions
  • 9.8 Cancer Historic and Forecast Sales by Regions
  • 9.9 GvHD Historic and Forecast Sales by Regions
  • 9.10. Others Historic and Forecast Sales by Regions

10 . GLOBAL MESENCHYMAL STEM CELLS MARKET ANALYSIS BY APPLICATION

  • 10.1 Overview by Application
  • 10.2 Historical and Forecast Data
  • 10.3 Analysis by Application
  • 10.4 Disease Modelling Historic and Forecast Sales by Regions
  • 10.5 Drug Development & Discovery Historic and Forecast Sales by Regions
  • 10.6 Stem Cell Banking Historic and Forecast Sales by Regions
  • 10.7 Tissue Engineering Historic and Forecast Sales by Regions
  • 10.8 Toxicology Studies Historic and Forecast Sales by Regions
  • 10.9 Others Historic and Forecast Sales by Regions

11 . GLOBAL MESENCHYMAL STEM CELLS MARKET ANALYSIS BY GEOGRAPHY

  • 11.1. Regional Outlook
  • 11.2. Introduction
  • 11.3. North America Sales Analysis
    • 11.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 11.3.2. North America By Segment Sales Analysis
    • 11.3.3. North America By Country Sales Analysis
    • 11.3.4. United State Sales Analysis
    • 11.3.5. Canada Sales Analysis
    • 11.3.6. Mexico Sales Analysis
  • 11.4. Europe Sales Analysis
    • 11.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 11.4.2. Europe by Segment Sales Analysis
    • 11.4.3. Europe by Country Sales Analysis
    • 11.4.4. United Kingdom Sales Analysis
    • 11.4.5. France Sales Analysis
    • 11.4.6. Germany Sales Analysis
    • 11.4.7. Italy Sales Analysis
    • 11.4.8. Russia Sales Analysis
    • 11.4.9. Rest Of Europe Sales Analysis
  • 11.5. Asia Pacific Sales Analysis
    • 11.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 11.5.2. Asia Pacific by Segment Sales Analysis
    • 11.5.3. Asia Pacific by Country Sales Analysis
    • 11.5.4. China Sales Analysis
    • 11.5.5. India Sales Analysis
    • 11.5.6. Japan Sales Analysis
    • 11.5.7. South Korea Sales Analysis
    • 11.5.8. Australia Sales Analysis
    • 11.5.9. Rest Of Asia Pacific Sales Analysis
  • 11.6. Latin America Sales Analysis
    • 11.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 11.6.2. Latin America by Segment Sales Analysis
    • 11.6.3. Latin America by Country Sales Analysis
    • 11.6.4. Brazil Sales Analysis
    • 11.6.5. Argentina Sales Analysis
    • 11.6.6. Peru Sales Analysis
    • 11.6.7. Chile Sales Analysis
    • 11.6.8. Rest of Latin America Sales Analysis
  • 11.7. Middle East & Africa Sales Analysis
    • 11.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 11.7.2. Middle East & Africa by Segment Sales Analysis
    • 11.7.3. Middle East & Africa by Country Sales Analysis
    • 11.7.4. Saudi Arabia Sales Analysis
    • 11.7.5. UAE Sales Analysis
    • 11.7.6. Israel Sales Analysis
    • 11.7.7. South Africa Sales Analysis
    • 11.7.8. Rest Of Middle East And Africa Sales Analysis

12 . COMPETITIVE LANDSCAPE OF THE MESENCHYMAL STEM CELLS COMPANIES

  • 12.1. Mesenchymal Stem Cells Market Competition
  • 12.2. Partnership/Collaboration/Agreement
  • 12.3. Merger And Acquisitions
  • 12.4. New Product Launch
  • 12.5. Other Developments

13 . COMPANY PROFILES OF MESENCHYMAL STEM CELLS INDUSTRY

  • 13.1. Company Share Analysis
  • 13.2. Market Concentration Rate
  • 13.3. Thermo Fisher Scientific Inc.
    • 13.3.1. Company Overview
    • 13.3.2. Company Revenue
    • 13.3.3. Products
    • 13.3.4. Recent Developments
  • 13.4. Cell Applications Inc.
    • 13.4.1. Company Overview
    • 13.4.2. Company Revenue
    • 13.4.3. Products
    • 13.4.4. Recent Developments
  • 13.5. Axol Biosciences Ltd.
    • 13.5.1. Company Overview
    • 13.5.2. Company Revenue
    • 13.5.3. Products
    • 13.5.4. Recent Developments
  • 13.6. Cytori Therapeutics Inc
    • 13.6.1. Company Overview
    • 13.6.2. Company Revenue
    • 13.6.3. Products
    • 13.6.4. Recent Developments
  • 13.7. STEMCELL Technologies
    • 13.7.1. Company Overview
    • 13.7.2. Company Revenue
    • 13.7.3. Products
    • 13.7.4. Recent Developments
  • 13.8. Cyagen Biosciences.
    • 13.8.1. Company Overview
    • 13.8.2. Company Revenue
    • 13.8.3. Products
    • 13.8.4. Recent Developments
  • 13.9. Celprogen Inc
    • 13.9.1. Company Overview
    • 13.9.2. Company Revenue
    • 13.9.3. Products
    • 13.9.4. Recent Developments
  • 13.10. BrainStorm Cell Limited.
    • 13.10.1. Company Overview
    • 13.10.2. Company Revenue
    • 13.10.3. Products
    • 13.10.4. Recent Developments
  • 13.11. Stemedica Cell Technologies Inc
    • 13.11.1. Company Overview
    • 13.11.2. Company Revenue
    • 13.11.3. Products
    • 13.11.4. Recent Developments
  • 13.12. Merck KGaA (MilliporeSigma)
    • 13.12.1. Company Overview
    • 13.12.2. Company Revenue
    • 13.12.3. Products
    • 13.12.4. Recent Developments
  • 13.13. Lonza
    • 13.13.1. Company Overview
    • 13.13.2. Company Revenue
    • 13.13.3. Products
    • 13.13.4. Recent Developments
  • 13.14. PromoCell GmbH
    • 13.14.1. Company Overview
    • 13.14.2. Company Revenue
    • 13.14.3. Products
    • 13.14.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Product & Services (USD MN)
  • Products (Cells & Cell Lines, Kits, Media, & Reagents, Others) Market Sales by Geography (USD MN)
  • Services Market Sales by Geography (USD MN)
  • Analysis Market by Workflow (USD MN)
  • Cell Sourcing & Isolation Market Sales by Geography (USD MN)
  • Culture & Cryopreservation Market Sales by Geography (USD MN)
  • Differentiation Market Sales by Geography (USD MN)
  • Characterization Market Sales by Geography (USD MN)
  • Analysis by Type (USD MN)
  • Autologous Market Sales by Geography (USD MN)
  • Allogeneic Market Sales by Geography (USD MN)
  • Analysis by Source Of Isolation (USD MN)
  • Bone Marrow Market Sales by Geography (USD MN)
  • Cord Blood Market Sales by Geography (USD MN)
  • Peripheral Blood Market Sales by Geography (USD MN)
  • Fallopian Tube Market Sales by Geography (USD MN)
  • Fetal Liver Market Sales by Geography (USD MN)
  • Lung Market Sales by Geography (USD MN)
  • Adipose Tissues Market Sales by Geography (USD MN)
  • Analysis by Indication (USD MN)
  • Bone And Cartilage Repair Market Sales by Geography (USD MN)
  • Cardiovascular Disease Market Sales by Geography (USD MN)
  • Inflammatory And Immunological Diseases Market Sales by Geography (USD MN)
  • Liver Diseases Market Sales by Geography (USD MN)
  • Cancer Market Sales by Geography (USD MN)
  • GvHD Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis by Application (USD MN)
  • Disease Modelling Market Sales by Geography (USD MN)
  • Drug Development & Discovery Market Sales by Geography (USD MN)
  • Stem Cell Banking Market Sales by Geography (USD MN)
  • Tissue Engineering Market Sales by Geography (USD MN)
  • Toxicology Studies Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Mesenchymal Stem Cells Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Mesenchymal Stem Cells Report
  • Market Research Process
  • Market Research Methodology
  • Global Mesenchymal Stem Cells Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Product & Services
  • Market Attractiveness Analysis by Workflow
  • Market Attractiveness Analysis by Type
  • Market Attractiveness Analysis by Source Of Isolation
  • Market Attractiveness Analysis by Indication
  • Market Attractiveness Analysis by Application
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Product & Services (USD MN)
  • Products (Cells & Cell Lines, Kits, Media, & Reagents, Others) Market Sales by Geography (USD MN)
  • Services Market Sales by Geography (USD MN)
  • Global Market Analysis by Workflow (USD MN)
  • Cell Sourcing & Isolation Market Sales by Geography (USD MN)
  • Culture & Cryopreservation Market Sales by Geography (USD MN)
  • Differentiation Market Sales by Geography (USD MN)
  • Characterization Market Sales by Geography (USD MN)
  • Global Market Analysis by Type (USD MN)
  • Autologous Market Sales by Geography (USD MN)
  • Allogeneic Market Sales by Geography (USD MN)
  • Global Market Analysis by Source Of Isolation (USD MN)
  • Bone Marrow Market Sales by Geography (USD MN)
  • Cord Blood Market Sales by Geography (USD MN)
  • Peripheral Blood Market Sales by Geography (USD MN)
  • Fallopian Tube Market Sales by Geography (USD MN)
  • Fetal Liver Market Sales by Geography (USD MN)
  • Lung Market Sales by Geography (USD MN)
  • Adipose Tissues Market Sales by Geography (USD MN)
  • Global Market Analysis by Indication (USD MN)
  • Bone And Cartilage Repair Market Sales by Geography (USD MN)
  • Cardiovascular Disease Market Sales by Geography (USD MN)
  • Inflammatory And Immunological Diseases Market Sales by Geography (USD MN)
  • Liver Diseases Market Sales by Geography (USD MN)
  • Cancer Market Sales by Geography (USD MN)
  • GvHD Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by Application (USD MN)
  • Disease Modelling Market Sales by Geography (USD MN)
  • Drug Development & Discovery Market Sales by Geography (USD MN)
  • Stem Cell Banking Market Sales by Geography (USD MN)
  • Tissue Engineering Market Sales by Geography (USD MN)
  • Toxicology Studies Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.